merck & co. inc. (MRK:New York)
Beth C. Seidenberg M.D.
Former Senior Executive in Research & Development, Merck & Co. Inc.
|Age||Total Calculated Compensation||This person is connected to 116 board members in 15 different organizations across 18 different industries.|
See Board Relationships
Dr. Beth C. Seidenberg, M.D., is a Partner, General Partner and Investment Partner at Kleiner Perkins Caufield & Byers. Dr. Seidenberg is a part of the life sciences team and focuses on Pandemic and Biodefense investing. She works with entrepreneurs to develop companies with breakthrough technology to treat patients and improve health. She joined the KPCB in 2005 and has incubated five companies. She serves as the Chairman and Founder of NVCA-MedIC coalition focusing ...
One Merck DrivePhone: 908-423-1000
Whitehouse Station, New Jersey 08889
Board Members Memberships*
Former Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director and Member of Audit Committee
Non-Employee Director and Chairman of Nominating & Corporate Governance Committee
University Of Miami School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Robert J. Hugin MBA||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Lars Rebien Sørensen||Chief Executive Officer and Member of Executive Management|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|